US › Healthcare

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)

US · Healthcare · Biotechnology

$2.22+2.78%

Last close · 2026-08-04

Key statistics

Market cap

$3.5M

Forward P/E

0.0

P/B

0.00

Book value

$-4.07

EPS (TTM)

$-3.26

52-week high

$9.82

52-week low

$0.58

50-day MA

$4.45

200-day MA

$12.46

Analyst view

with an average price target of $12.00.

Shareholding

Insiders

48.67%

Institutions

0.00%

Largest institutional holders

Fund	Stake
Ronald Blue Trust, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lakewood-Amedex Biotherapeutics Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.